Symbol Name ID |
Ackr4
atypical chemokine receptor 4 MGI:2181676 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Ackr4tm1.1Rjbn/Ackr4tm1.1Rjbn B6.129S6-Ackr4tm1.1Rjbn |
abnormal CD4-positive, alpha-beta T cell number | J:166490 |
abnormal CD4-positive, alpha-beta T cell physiology | J:166490 | |
abnormal chemokine level | J:166490 | |
abnormal circulating chemokine level | J:166490 | |
abnormal T-helper 17 cell differentiation | J:166490 | |
decreased T cell proliferation | J:166490 | |
increased interleukin-23 secretion | J:166490 | |
increased susceptibility to experimental autoimmune encephalomyelitis | J:166490 | |
increased T-helper 17 cell number | J:166490 | |
spleen hyperplasia | J:166490 | |
Ackr4tm1Ccbl/Ackr4+ involves: 129S1/Sv * 129X1/SvJ |
no abnormal phenotype detected | J:182799 |
Ackr4tm1Dgen/Ackr4tm1Dgen involves: 129P2/OlaHsd * C57BL/6 |
no abnormal phenotype detected | J:101679 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 08/02/2024 MGI 6.24 |
![]() |
|